Effects of l-arginine on the systemic, mesenteric, and Hepatic circulation in patients with cirrhosis
Open Access
- 1 February 1998
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 27 (2) , 377-382
- https://doi.org/10.1002/hep.510270210
Abstract
Nitric oxide (NO) is known to play an important role in modulating both the hepatic and mesenteric circulation under physiological and pathological conditions. We investigated how l-arginine, a precursor of NO, modifies the hepatic and mesenteric circulation in patients with cirrhosis. The study design was a single-blind controlled study. We measured the systemic and portal hemodynamics before and following intravenous l -arginine and saline infusion using pulsed Doppler ultrasonography in 20 patients with cirrhosis, and then the effects were compared with those found in 20 healthy subjects. In these patients, the effects of l-arginine on hepatic circulation were investigated using hepatic catheterization. l -Arginine infusion induced systemic vasodilation in both the healthy controls and the cirrhotic patients in a similar hemodynamic manner. In these patients, the l-arginine-induced increase in the portal flow was significantly higher than that of cardiac output (CO); however, the relation was the inverse in healthy subjects. Moreover, the l-arginine-induced increase in the portal flow was greater in the cirrhotic patients than that seen in healthy subjects. As a result, l-arginine infusion was thus found to selectively augment the hepatopetal portal blood flow in the cirrhotic liver. In patients, l-arginine infusion induced marked hepatic vasodilation as demonstrated by the reduced hepatic sinusoidal resistance (HSR) and increased estimated hepatic blood flow (EHBF) associated with the ameliorated intrinsic clearance of indocyanine green. Despite the fall in HSR, the hepatic venous pressure gradient (HVPG) increased following l-arginine infusion. The mesenteric and hepatic vascular areas of cirrhosis exhibited an increased susceptibility to the dilator action of l -arginine. These findings suggest that the enhanced NO production in the splanchnic vascular area has an important role in the hepatic circulation in patients with cirrhosis.Keywords
This publication has 27 references indexed in Scilit:
- Endothelin Induced Contractility of Stellate Cells From Normal and Cirrhotic Rat Liver: Implications for Regulation of Portal Pressure and ResistanceHepatology, 1996
- The Hypotensive Effect of L-Arginine Is Associated With Increased Expired Nitric Oxide in HumansChest, 1996
- Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cellsGastroenterology, 1996
- Inducible nitric oxide synthase in rat hepatic lipocytes and the effect of nitric oxide on lipocyte contractility.Journal of Clinical Investigation, 1995
- Endothelin receptors in rat liver: lipocytes as a contractile target for endothelin 1.Proceedings of the National Academy of Sciences, 1993
- Roles of endothelin-1 and nitric oxide in the mechanism for ethanol-induced vasoconstriction in rat liver.Journal of Clinical Investigation, 1993
- l‐ARGININE INFUSION INDUCES HYPOTENSION AND DIURESIS/NATRIURESIS WITH CONCOMITANT INCREASED URINARY EXCRETION OF NITRITE/NITRATE AND CYCLIC GMP IN HUMANSClinical and Experimental Pharmacology and Physiology, 1992
- L-arginine-induced hypotensionThe Lancet, 1990
- General and regional circulatory alterations in cirrhosis of the liverThe American Journal of Medicine, 1964
- Circulatory changes in chronic liver diseaseThe American Journal of Medicine, 1958